4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Scinai Immunotherapeutics Ltd. (SCNI) operates in the Biotechnology industry and is headquartered in Jerusalem, Israel with about 45 employees. Its market capitalization is roughly $1 million. In the fiscal year ended 2025-12-31, SCNI reported $1M in revenue and ($8M) in net income.
Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally.
Interactive charts & full statements → Open the SCNI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $0M | $0M | — |
| Gross Profit | ($3M) | ($1M) | $0M | $0M | — |
| Operating Income (EBIT) | ($8M) | ($9M) | ($10M) | ($11M) | — |
| Net Income | ($8M) | $5M | ($6M) | ($6M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $0M |
| Gross Profit | ($1M) | ($1M) | ($2M) | $0M | ($0M) |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) |
| Net Income | ($2M) | $4M | ($3M) | ($2M) | ($2M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $12M | $13M | $18M | $27M | — |
| Total Liabilities | $4M | $4M | $22M | $29M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SCNI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms